Rivas A, Koide J, Laus R, Engleman E G
Department of Pathology, Stanford University School of Medicine, CA 94305.
J Immunol. 1990 Jul 15;145(2):470-6.
The vast majority of circulating lymphocytes that express the alpha,beta TCR in association with CD3 also express either CD4 or CD8 molecules, which are thought to act as important accessory structures in HLA class II- and I-restricted T cell functions, respectively. In the current study alpha,beta TCR+ clones devoid of detectable CD4 or CD8 were generated by repeated stimulation of fresh CD3+,CD4-,CD8- cells with an allogeneic lymphoblastoid cell line in the presence of conditioned medium containing IL-2. Except for the absence of CD4 and CD8, which was associated with undetectable levels of CD4 and CD8 mRNA, the clones were phenotypically indistinguishable from classical CD3+,alpha,beta TCR+ cells. Furthermore, they mediated potent cytolysis of their specific stimulator line but did not kill irrelevant LCL or NK-sensitive targets. mAb to CD3 and the alpha,beta TCR inhibited cytolysis, suggesting that the clones use the TCR/CD3 complex to recognize and respond to their targets. mAbs to CD2 and CD11a also inhibited cytolysis, indicating that the clones use these accessory molecules to interact with their targets. Finally, cytolysis was inhibited by an HLA-A,B,C framework-specific mAb (W6/32) as well as a mAb (MA2.1) specific for an HLA-A2 epitope. These results demonstrate that CD3+,alpha,beta TCR+,CD4-,CD8- cytotoxic clones can be generated from the peripheral blood of healthy adults, and use their TCR/CD3 complexes to function in an HLA class I-restricted manner.
绝大多数与CD3相关联表达αβTCR的循环淋巴细胞也表达CD4或CD8分子,它们分别被认为在HLA II类和I类限制性T细胞功能中起重要的辅助结构作用。在本研究中,通过在含有IL-2的条件培养基存在下,用同种异体淋巴母细胞系反复刺激新鲜的CD3 +、CD4 -、CD8 -细胞,产生了缺乏可检测到的CD4或CD8的αβTCR +克隆。除了缺乏与无法检测到的CD4和CD8 mRNA水平相关的CD4和CD8外,这些克隆在表型上与经典的CD3 +、αβTCR +细胞没有区别。此外,它们介导对其特异性刺激细胞系的强力细胞溶解,但不杀伤无关的LCL或NK敏感靶细胞。抗CD3和αβTCR的单克隆抗体抑制细胞溶解,表明这些克隆利用TCR/CD3复合物识别并响应其靶细胞。抗CD2和CD11a的单克隆抗体也抑制细胞溶解,表明这些克隆利用这些辅助分子与靶细胞相互作用。最后,细胞溶解被HLA-A、B、C框架特异性单克隆抗体(W6/32)以及针对HLA-A2表位的单克隆抗体(MA2.1)抑制。这些结果表明,CD3 +、αβTCR +、CD4 -、CD8 -细胞毒性克隆可从健康成年人外周血中产生,并以HLA I类限制性方式利用其TCR/CD3复合物发挥功能。